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Abstract
Background/Objectives: To evaluate the predictive value of CT-derived measurements of the aortic annulus for prosthesis
sizing in transcatheter aortic valve implantation (TAVI) and to calculate optimal cutoff values for the selection of various
prosthesis sizes.
Methods: The local IRB waived approval for this single-center retrospective analysis. Of 441 consecutive TAVI-patients, 90
were excluded (death within 30 days: 13; more than mild aortic regurgitation: 10; other reasons: 67). In the remaining 351
patients, the CoreValve (Medtronic) and the Edwards Sapien XT valve (Edwards Lifesciences) were implanted in 235 and 116
patients. Optimal prosthesis size was determined during TAVI by inflation of a balloon catheter at the aortic annulus. All
patients had undergone CT-angiography of the heart or body trunk prior to TAVI. Using these datasets, the diameter of the
long and short axis as well as the circumference and the area of the aortic annulus were measured. Multi-Class Receiver-
Operator-Curve analyses were used to determine the predictive value of all variables and to define optimal cutoff-values.
Results: Differences between patients who underwent implantation of the small, medium or large prosthesis were
significant for all except the large vs. medium CoreValve (all p’s,0.05). Furthermore, mean diameter, annulus area and
circumference had equally high predictive value for prosthesis size for both manufacturers (multi-class AUC’s: 0.80, 0.88,
0.91, 0.88, 0.88, 0.89). Using the calculated optimal cutoff-values, prosthesis size is predicted correctly in 85% of cases.
Conclusion: CT-based aortic root measurements permit excellent prediction of the prosthesis size considered optimal
during TAVI.
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Aortic valve stenosis is the most common acquired valve
disorder and symptomatic forms have dismal outcomes when
treated medically [1,2]. For decades, surgical valve replacement
has been the only curative treatment – however, due to
comorbidities at the time of presentation up to one third of
patients cannot undergo open heart surgery [3–5]. Transcatheter
Aortic Valve Implantation (TAVI)/Transcatheter Aortic Valve
Replacement (TAVR) is a novel, less invasive technique and is
comparably safe even in patients with contraindications to surgery
[6,7]. Results of the randomized controlled PARTNER-B-cohort
comparing TAVI to best medical therapy have shown substantial
survival benefits after 12 and 24 months [8,9]. In patients with a
high surgical risk (PARTNER-A-cohort), TAVI was non-inferior
to surgery after 12 months [10].
Unlike in surgical replacement, prosthesis sizing for TAVI
significantly relies on imaging [11]. Imaging-derived measure-
ments of the aortic root play the key role in patient and device
selection. Transesophageal echocardiography and Multidetector
PLOS ONE | www.plosone.org 1 August 2014 | Volume 9 | Issue 8 | e103481
–
–
CT-angiography (CTA) have been applied extensively in this
regard [12–14]. Several studies have consistently demonstrated
that the aortic annulus has an elliptic shape described by a long
and short axis with a wide range of reported eccentricities [15,16].
As a consequence, it is difficult to measure the true dimensions of
the aortic annulus on the basis of a single plane obtained by 2D-
echocardiography [17,18].
There is initial evidence favoring CTA over echocardiography
for prosthesis selection. Recently, Jilaihawi et al had demonstrated
for the SAPIEN XT valve (Edwards Lifesciences) that annular-
sizing on the basis of CT resulted in lower rates of paravalvular
regurgitation than sizing on the basis of 2D TEE [17]. Similar
results had previously been reported by Hayashida et al for
patients having undergone implantation of the Corevalve (Med-
tronic) or Sapien XT valve (Edwards Lifesciences) [19].
Several questions remain as to how select the optimal prosthesis
size on the basis of CT-derived annulus parameters and most
authors use a fixed algorithm suggesting certain annulus diameter
ranges for distinct prosthesis sizes. Recently, Binder et al reported
that the application of a CT-based annulus area sizing algorithm
prior to TAVI resulted in the reduction of paravalvular
regurgitation compared with simply providing quantitative results
for anatomical parameters [20].
In this study, we analyzed all patients (n = 351) who had
undergone dedicated CT-angiography prior to TAVI at our
institution. We report descriptive statistics for the key anatomic
parameters of the aortic root, determine interobserver reproduc-
ibility for CT-derived measurements and analyze various ana-
tomic variables for their predictive value for the selection of
optimal device size. Suggestions are provided for optimal cutoff
values for CT-based measurements.
Methods
1. Patient Population
This analysis included patients with severe aortic valve stenosis
who underwent a TAVI procedure at our institution between
November 2007 and June 2012. Patients needed to have
undergone CTA for the evaluation of aortic root anatomy within
three months before TAVI. As all CT scans were performed as
part of routine clinical workup and were analyzed anonymously,
Figure 1. Inclusion chart for our analysis of 351 patients who underwent a successful TAVI procedure.
doi:10.1371/journal.pone.0103481.g001
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the institutional review board of the Faculty of Medicine of the
Ludwig Maximilian University of Munich waived the necessity to
obtain consent beyond routine clinical requirements. All patients
gave written consent to an anonymous analysis of the acquired
data.
According to institutional policies patients with impaired renal
function (glomerular filtration rate ,30 ml/min), abnormal TSH-
levels or a history of allergic reaction to iodine-containing contrast
agents were excluded. After explicit education about the risks of
iodinated contrast agents and exposure to x-rays, written informed
consent was obtained (Figure 1).
2. CT Data Acquisition and Image Reconstruction
CT scans were performed either on a first-generation dual-
source MDCT scanner (n = 49, Somatom Definition, Siemens
Healthcare, Forchheim, Germany) or on a second-generation
dual-source MDCT scanner (n = 302, Somatom Definition Flash,
Siemens Healthcare) 3–90 days before TAVI. The ECG-signal
was registered continuously throughout the scan. Images of the
heart were acquired during diastole. Slice collimation was
266460.6 mm (first generation) or 2612860.6 mm (second
generation). Tube potential was 100 or 120 kV (depending on
patient weight) and effective tube current-time product was 350–
400 mAs/rotation. See Appendix S1 for detailed scan parameters.
In all patients, 90 ml of iomeprol 816.5 g/l (Imeron 400, Bracco
Imaging, Milan, Italy) were administered via an ante-cubital vein
at a flow-rate of 4 ml/s, followed by 100 ml of normal saline at the
same flow rate. Contrast enhancement was controlled by bolus
tracking within the ascending aorta.
Figure 2. Examples of anatomic measurements at the aortic annulus performed for this study: isotropic small field-of-view CTA dataset
of a 78 year old female patient with severe aortic stenosis, A) sagittal reformation and B) coronal reformation showing the orientation of the aortic
annulus plane, C) double-oblique reformation of the aortic valve annulus, demonstrating the diameter of the long axis (black line), the diameter of
the short axis (blue line), the annulus circumference (red polygonal), and annulus area (yellow shading). D) angiographic image after implantation of a
26 mm model of the Edward Sapien XT valve prosthesis demonstrates no paravalvular leakage.
doi:10.1371/journal.pone.0103481.g002
CTA-Based Aortic Annulus Measurement Prior to TAVI
PLOS ONE | www.plosone.org 3 August 2014 | Volume 9 | Issue 8 | e103481
Once intraluminal attenuation exceeded 150 HU, the table was
repositioned for the desired scan range. Delay was 6 seconds
(Somatom Definition) or 12 seconds (Somatom Definition Flash).
Thereafter, the start of the scan was triggered by ECG
automatically.
A medium-smooth convolution kernel was used to generate
standard coronary CTA reconstructions (small field of view, slice
thickness 0.75 mm, reconstruction increment 0.5 mm covering the
entire heart). All series were pseudonymized and transferred to an
external workstation.
3. CT Data Analysis
Two experienced readers analyzed all series independently
using commercially available software (Syngo Via VA20, Siemens
Healthcare, Germany). Readers determined subjective image
quality and contrast enhancement on 4-point Likert scales (4:
best image quality/contrast enhancement, 1: poor image quality/
contrast enhancement). Furthermore, both readers measured the
size of the aortic annulus according to techniques suggested by
various authors [12,21–23]. Using multiplanar reformations,
readers independently established the double-oblique plane
defined by the three ‘hinge’ points (i.e. the most apical points of
the valvular cusps, see Figure 2). On this plane, both readers
manually determined the lengths of the long axis (LA), short axis
(SA), circumference (C) and area (A) of the elliptical shape of the
the aortic valve annulus (Figure 2). Three virtual diameters (dmean,













4. Clinical and procedural data
In all patients, TAVI was performed at the department of
cardiology of this institution as part of routine clinical care.
Patients were admitted at least 1 day prior to TAVI and
transferred to a high-level intensive care unit for at least 24 hours
afterwards. All patients underwent a routine transthoracic
echocardiography exam within 7 days prior to TAVI.
Selection of valve type (CoreValve by Medtronic, Minneapolis,
USA vs. Edward Sapien XT by Edwards Lifesciences, Irvine, CA,
USA) and size was performed by the heart team members before
and during TAVI. According to the standard operating proce-
dures of this institution, an initial estimation of annulus size was
performed based on all available imaging information. During the
procedure, a balloon catheter with the estimated size was inflated
at the annulus position and snug fit was evaluated by fluoroscopy
and balloon pressures [24–26]. Depending on the appearance of
the balloon and the recorded pressures, valve size was either
confirmed or changed. In the latter case, a different balloon
catheter was used and the changed size tested. Once optimal size
had been established, the respective valve was implanted using the
techniques recommended by manufacturers. Thereafter, conven-
tional angiography was performed to test for aortic regurgitation,
which was rated on a three point Likert scale (1: no, minimal or
first degree regurgitation, 2: second degree regurgitation, 3: severe
regurgitation).
5. Statistical Analysis
The D’Agostino-Pearson test was used to test for normal
distribution of continuous variables. Continuous variables are
reported as mean 6 standard deviation when normally distribut-
ed, otherwise as median (interquartile range).
For categorical variables, Cohen’s kappa was used to address
observer agreement and was reported with 95% confidence
interval. For continuous variables, the intraclass correlation
coefficient (ICC) was used [27].
Differences in proportions were assessed using the Chi-squared
test. To test for differences in means of interval variables, the
Student’s t-test (for independent or paired samples) was applied if
variables followed normal distribution. For comparison of means
of three or more variables, a one-way analysis of variance
(ANOVA) was performed. If significant differences were found,
variables were compared using the Tukey-HSD post-hoc test with






n 351 (100%) 235 (67%) 116 (33%)
Female Patients 211 (58%) 132 (54%) 74 (62%) 0.18
Age at scan (yrs) 80.9610.8 81.666.5 76.3621.5 0.06
Height (cm) 165.768.9 165.5613.9 163.2618.2 0.125
Weight (kg) 72.9614.7 72.6615.0 72.1617.0 0.83
BMI (kg/m2) 26.564.8 26.364.5 26.865.4 0.62
Aortic Valve Area (cm2) 0.7060.15 0.6960.16 0.7260.13 0.21
Pressure gradient (mmHg) 66.9622.4 67.3623.8 66.0619.6 0.65
Ejection fraction (%) 58.0615.3 57.8616.0 58.3613.6 0.80
Logistic EuroSCORE 18.9 [13.4; 25.7] 19.6 [14.5; 26.7] 16.5 [11.0; 23.4] ,0.01
Valve Sizes:
Small Size 131 (37%) 93 (40%) 38 (33%) 0.25
Medium Size 207 (59%) 135 (57%) 72 (62%) 0.44
Large Size 13 (4%) 7 (3%) 6 (5%) 0.52
doi:10.1371/journal.pone.0103481.t001
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application of Bonferroni corrections to avoid errors due to
multiple testing.
To compare means in variables not following normal distribu-
tion, a t-test was used if normal distribution was approximated
after logarithmic transformation. In all other cases, non-paramet-
ric tests were used: the Mann-Whitney-test for independent
variables and the Wilcoxon signed-rank test for paired variables.
To identify cut-off points that allow optimal prediction of
implanted valve size on the basis of the particular anatomic
parameter, and to estimate the associated generalization perfor-
mance, we applied a 10-fold nested cross-validation approach.
Details regarding this approach are included in Appendix S1.
P-values of 0.05 or less were considered statistically significant
unless otherwise stated. Data were analyzed using MedCalc
(Version 9.3.0.0, MedCalc Software, Mariakerke, Belgium), SPSS
(21.0, IBM, Armonk, USA) and R [28].
Results
1. Patient Population
Between November 2007 and June 2012, 441 consecutive
patients with high-grade aortic stenosis (mean AVA: 0.70 cm2,
SD: 0.15 cm2) underwent a TAVI procedure at our institution. Of
these, 17 patients were excluded as they presented with secondary
stenosis of a surgical aortic valve prosthesis. Another 49 patients
presented with externally acquired CT angiography datasets and
were also excluded from this analysis. Of the remaining patients,
13 had died within 30 days after procedure and were not included
into further analysis. 10 patients were excluded as they showed
more than mild aortic regurgitation after valve implantation.
Finally, one patient was excluded due to an error during archiving
the small FOV (cardiac) series to PACS (Figure 1).
Of the remaining 351 patients, 235 had undergone implanta-
tion of a CoreValve prosthesis while in the remaining 116 patients
the Edwards Sapien XT valve had been implanted. While
differences in demographic parameters and preinterventional
echocardiographic parameters between patients who underwent
CoreValve vs. Edward Sapien XT valve implantation were not
statistically significant, there was a difference in logarithmic Euro-
Scores (19.6 [14.5; 26.7] vs. 16.5 [11.0; 23.4], p,0.01, see Table 1
for a summary of patient parameters) demonstrating a moderately
less favorable risk profile in the CoreValve subgroup. In the entire
cohort, no adverse events due to iv contrast administration during
CT angiography were reported.
2. Subjective image quality and contrast enhancement of
CTA datasets
There was substantial interobserver agreement for both
subjective overall image quality (kappa = 0.76 [0.69–0.82]) and
contrast enhancement (kappa = 0.72 [0.67–0.77]). Therefore,
values from reader one were used for further analysis. Mean
subjective image quality was 3.66 (SD: 0.58) and mean contrast
enhancement was 3.88 (SD: 0.43).
3. CT-based anatomical measures of the aortic root
Interobserver agreement was excellent for all parameters with
ICC-values consistently above 0.80. Bland-Altman-Analysis re-
vealed no relevant systematic differences (Table 2 and Appendix
S2). Therefore, arithmetic means between both observers were
calculated for all variables.
Table 3 provides descriptive statistics on aortic valve measure-
ments. Across all patients, length of the long axis and short axis
were 2.70 [2.52; 2.90] and 2.05 [1.95; 2.25], respectively, and
were slightly larger in the CoreValve subgroup than in the Edward
Sapien subgroup (see Table 3). Median circumferences and
median areas were 7.65 [7.28; 8.15] cm and 4.34 [3.90; 4.95]
cm2. There was a small but significant difference in average
annulus diameters derived from circumference (2.44 [2.32; 2.60]
cm) vs. those derived from annulus area (2.35 [2.23; 2.51] cm,
p,0.01).
4. Annulus dimensions for different valve sizes
Of the 235 patients who underwent implantation of a
CoreValve prosthesis, the 26 mm, 29 mm and 31 mm models
were chosen in 93 (40%, 93/235), 135 (57%, 135/235) and 7 (3%,
7/235) cases. In 116 patients who received the Edward Sapien XT
valve, the 23 mm, 26 mm and 29 mm were implanted in 38 (33%,
38/116), 72 (62%, 72/116) and 6 (5%, 6/118) cases.
Figure 3 provides details on long axis diameter, short axis
diameter, circumference-derived and area-derived average annu-
lus diameter measured for different sizes of CoreValve (Figure 3A)
and Edward Sapien XT (Figure 3B). For all analyzed variables,
one-way ANOVA showed significant differences between patients
who underwent implantation of the small, middle or large valve
(for the CoreValve: 26 mm, 29 mm, 31 mm; for the Edward
Sapien XT: 23 mm, 26 mm, 29 mm, both p’s,0.01). In Tukey-
HSD post-hoc tests, differences between all size subgroups were
statistically significant except for patients who underwent implan-
tation of the CoreValve 31 mm vs. 29 mm (p.0.05), which was
most likely due to the relatively small number of patients in the
31 mm CoreValve subgroup (n = 7).
Figure 3. Summary chart displaying major anatomic parameters (length of long and short axis; circumference-derived and area-
derived virtual diameter) in patients in whom the small, medium or large size model was considered optimal for A) the CoreValve
valve and the B) Edward Sapien XT valve. Except for the large vs. medium CoreValve size, all differences were statistically significant (p,0.05).
doi:10.1371/journal.pone.0103481.g003
Table 2. Interobserver Agreement for anatomical measurements of the aortic root reported as Intraclass Correlation Coefficient
(ICC) and parameters of Bland-Altman-Analysis.
Diameter long axis Diameter short axis DiameterMean Annulus Circum-ference Annulus Area
ICC [95% CI] 0.87 [0.84; 0.89] 0.86 [0.83; 0.88] 0.90 [0.88; 0.92] 0.92 [0.90; 0.93] 0.93 [0.92; 0.94]
Mean difference 0.00 cm 0.00 cm 0.00 cm 0.06 cm 0.03 cm2
SD of differences 0.14 cm 0.12 cm 0.20 cm 0.54 cm 0.6 cm2
doi:10.1371/journal.pone.0103481.t002
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5. Predictive value of different variables for device size
selection and optimal cutoff values
Using multi-class ROC-analysis, the predictive value of all
anatomic parameters for the size of prosthesis considered optimal
was evaluated. For both valve types, all five analyzed parameters
showed high predictive value for optimal prosthesis size (AUC:
0.75–0.91, Table 4). In particular, for the Medtronic CoreValve
the short axis had a somewhat lower predictive value (multi-class
AUC: 0.75) while there were no differences in predictive value
between diameters of long axis, mean diameter, annulus area or
annulus circumference (multi-class AUC’s: 0.81, 0.80, 0.88, 0.9,
p.0.05, Appendix S3). For the Edwards Sapien XT valve,
differences in predictive value between the different parameters
also did not reach statistical significance (multi-class AUC’s: 0.83,
0.80, 0.88, 0.88, 0.89, p.0.05, Appendix S4). Application of the
proposed cutoff-values in our sample of 351 patients results in the
correct classification of 81.5% (286/351), 85.5% (300/351) and
82.9% (291/351) of cases if annulus circumference, annulus area
or mean diameter are used.
Discussion
Transcatheter aortic valve implantation (TAVI) has been
developed as a treatment strategy for patients with severe aortic
stenosis who are at high risk or not eligible for heart surgery [29].
Several studies have demonstrated that MDCT is an ideal imaging
modality prior to TAVI, providing isotropic datasets of the aortic
root that can be reformatted in any spatial orientation [30–32].
There is some evidence favoring CT-derived annulus sizing over
transthoracic echocardiography, particularly in regard to the
incidence of postinterventional aortic regurgitation [17,19].
Several methods have been proposed to reduce the shape of the
aortic annulus to a single measure for prosthesis sizing: calculation
of the arithmetic mean between long and short axis [21],
measurement of the length of the annulus circumference [12] or
quantification of the annulus area [22,23]. To date, no consensus
has been established on what the best technique is.
Binder et al have recently demonstrated for the Sapien XT
valve that the recommendation of a particular prosthesis size on
the basis of CT data results in more favorable outcomes than
simply providing the annulus parameters [20]. In this regard
Table 3. Primary anatomic parameters of the aortic annulus, N(%), mean 6 SD or median [interquartile range] as well as ‘‘virtual






Diameter Long Axis [cm] 2.70 [2.52; 2.90] 2.75 [2.54; 2.90] 2.65 [2.50; 2.85] 0.049
Diameter Short Axis [cm] 2.05 [1.95; 2.25] 2.10 [1.95; 2.28] 2.05 [1.90; 2.20] ,0.01
Circumference [cm] 7.65 [7.28; 8.15] 7.73 [7.30; 8.25] 7.55 [7.05; 8.00] ,0.01
Area [cm2] 4.34 [3.90; 4.95] 4.44 [3.98; 5.05] 4.19 [3.70; 4.75] ,0.01
DiameterMean [cm] 2.40 [2.25; 2.55] 2.42 [2.27; 2.58] 2.35 [2.22; 2.52] ,0.01
Circumference- derived
virtual diameter [cm]
2.44 [2.32; 2.60] 2.46 [2.32; 2.63] 2.40 [2.24; 2.55] ,0.01
Area-derived virtual
diameter [cm]
2.35 [2.23; 2.51] 2.38 [2.25; 2.54] 2.31 [2.17; 2.46] ,0.01
doi:10.1371/journal.pone.0103481.t003
Table 4. Multi-Class AUC’s as measures for the predictive value of the respective anatomic parameters for the valve size





MEDIUM vs. LARGE MULTI-CLASS AUC
MEDTRONIC COREVALVE Diameter Long Axis 2.70 cm 3.04 cm 0.8133
Diameter Short Axis 2.05 cm 2.29 cm 0.7478
DiameterMean 2.35 cm 2.70 cm 0.7974
Annulus Area 4.30 cm2 5.72 cm2 0.8812
Annulus Circumference 7.65 cm 8.60 cm 0.9146
EDWARDS SAPIEN
XT
Diameter Long Axis 2.55 cm 3.05 cm 0.8347
Diameter Short axis 1.95 cm 2.30 cm 0.7995
DiameterMean 2.25 cm 2.55 cm 0.8793
Annulus Area 3.85 cm2 5.35 cm2 0.8823
Annulus Circumference 7.15 cm 8.20 cm 0.8884
Optimal cutoff values for the selection of the small, medium or large prosthesis size, defined as cutoff values that result in highest predictive accuracy.
doi:10.1371/journal.pone.0103481.t004
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however, uncertainty remains as to what the optimal size of
prosthesis is for a given set of aortic annulus parameters.
In this analysis of over 350 patients who had undergone CT
angiography prior to TAVI, we performed extensive anatomic
measurements of the aortic root. Our results confirm previous
analyses of Halpern et al [14], Gurvitch et al [12] and Delgado et
al [33], since all relevant anatomic parameters can be measured in
virtually all patients with excellent agreement between two
experienced observers. Similar to the study by Gurvitch, observer
agreement was highest for aortic annulus circumference and area
(ICC’s = 0.92, 0.93), even though in our study differences to
observer agreement for long and short axis measurements were
not significant.
In all patients included in this analysis, optimal prosthesis size
was determined with the help of a sizing balloon catheter inflated
during the implantation procedure [24–26]. Furthermore, all
patients in whom this method might not have resulted in the
selection of the correct prosthesis size – i.e. patients with more
than mild regurgitation after TAVI (n = 10) and patients who died
within 30 days after implantation (n = 13) – were deliberately
excluded. No patient had to be excluded due to open heart surgery
within 30 days. According to best professional judgment,
prosthesis sizing was adequate in the remaining 351 patients.
Thus, our data permit the unique opportunity to analyze the
relation between different anatomic variables of the aortic root
and the device size ultimately considered optimal. Even more
importantly, the discriminatory power of different anatomic
variables to predict prosthesis size as well as optimal cutoff values
can be calculated.
Our results demonstrate that for all analyzed anatomic variables
there are differences between patients who underwent implanta-
tion of the small, medium or large valve. Our results are both in
line with but also extend those of Jilaihawi et al [17] and Delgado
et al [34], demonstrating that on the basis of high-resolution
MDCT datasets of the aortic root, the optimal valve size can be
predicted. While in principle all evaluated anatomic parameters
can be used for prosthesis sizing, the most favorable combination
of high observer agreement and predictive value are observed for
mean diameter, annulus area and annulus circumference (with
multi-class AUC’s of 0.88 and 0.91). Optimal thresholds for the
selection of the small, medium or large size are given in Table 4.
The use of these cutoff values in our cohort results in the
correction prediction of valve size in 85% (300/351) of cases. In
the remaining 15% (51/351), the application of a sizing balloon
would result in a change of device size. Importantly, our 2-
threshold-model does not take into account that a considerable
number of patients will be suitable candidates for two valve sizes.
Inclusion of the extent of aortic valve calcifications might further
increase the predictive accuracy of our model.
Our single-center retrospective study has several limitations:
first, the heart team members involved in valve implantation were
not blinded towards the routine radiological reports derived from
the CT dataset. While this would have been favorable from a
scientific perspective, we feel that the information obtained from
high-resolution CT angiography datasets prior to TAVI is of so
essential a nature that withholding it would be clearly unethical.
Furthermore, cardiologists integrated all available information
regarding valve size, including transthoracic and transesophageal
echocardiography and aortic angiography usually conducted
before the TAVI procedure. In every single case, the presumed
optimal valve size was simulated with a balloon catheter and
changed if the size of the inflated balloon and the aortic annulus
did not display the estimated ratio during aortography.
Second, we did not compare our measurements with a reference
imaging modality such as 3D-echocardiography or MR angiog-
raphy. However, our reference standard is the size of the
implanted valve in those patients in whom – according to best
professional judgment – prosthesis size turned out to be reasonably
selected. For the purpose of this analysis we consider this outcome-
oriented reference standard superior.
Third, we used only diastolic CT acquisitions to measure aortic
annulus dimensions. However, it still is a matter of debate if
systolic reconstructions are necessary for a reliable sizing of the
aortic valve annulus: while some authors propose systolic
reconstructions to avoid undersizing [35,36], others report no
difference [37] or no substantial difference [38] between systolic
and diastolic diameters. However, since we correlate our diastolic
measures of annulus parameters with the prosthesis size considered
optimal during implantation, a potential difference between
systolic and diastolic dimensions is not a major concern; our
results should rather be construed as a contribution to a prosthesis
sizing algorithm from diastolic annulus parameters.
Fourth, we do not perform an analysis of the patients in whom
valve implantation was not successful. However, the main
intention of our manuscript is to perform a rigorous analysis of
the dependencies between anatomical parameters of the aortic
annulus and the implanted valve size for patients in whom the
procedure was performed successfully. In that sense, we do not
attempt to prove that an inadequate selection of prosthesis size
increases the risk of a negative procedural outcome.
Finally, while our analysis suggests an ideal strategy to predict
the appropriate valve size, we cannot answer the question how this
strategy would perform in a prospective study context. However,
the rate of excluded patients is comparatively small: only 23
patients had to be excluded due to either death within 30 days
after the TAVI procedure (n = 13) or due to the development of
more than mild aortic regurgitation (n = 10). Therefore, we are
confident that our approach would permit a correct estimation of
correct valve size in the vast majority of cases.
In conclusion, our analysis of 351 patients who successfully
underwent TAVI shows that the valve size ultimately considered
optimal can be predicted on the basis of CT-derived anatomic
parameters of the aortic root. Mean diameter, annulus circumfer-
ence and annulus area appear to have equally high reproducibility
and predictive accuracy for both the Medtronic CoreValve and
the Edwards Sapien XT prostheses. It remains to be shown that
this approach holds up its predictive potential in a prospective
study context.
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